Anti-EPCR autoantibodies in ulcerative colitis show sex- and lipid-dependent patterns
Lopez-Sagaseta, J.; Ugidos-Damboriena, N.; Jaime-Gomez, L.; Rodriguez-Gutierrez, C.; Zabalza, L.; Nantes-Castillejo, O.; Dichiara-Rodriguez, M. G.
Show abstract
Autoantibodies targeting the endothelial protein C receptor (EPCR) have been associated with ulcerative colitis (UC). We aimed to assess a potential role of EPCR lipidation on the detection of anti-EPCR antibodies in inflammatory bowel disease (IBD). To this end, serum samples from patients with UC, Crohns disease, and healthy controls were analyzed using an in-house ELISA employing either native or delipidated EPCR. Overall, male UC patients showed significantly higher absorbance (mean=1.09) than CD patients (mean=0.50) and controls (mean=0.37). Remarkably, in males, the difference between UC patients and controls was highly significant (p=1.2e-07), as was the difference between UC and CD patients (p=5.7e-05). In women, the difference was less pronounced and only significant when comparing UC to controls (p=0.023). Replacement of native EPCR with delipidated EPCR in the ELISA procedure dropped detection and eliminated the UC-CD discrimination power (p=0.784). These findings indicate a role for the bound lipid as key determinant of male-biased, anti-EPCR reactivity, and support the diagnostic potential of this biomarker when assay conditions preserve the physiological lipid-bound state of EPCR.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Intestinal receptor of SARS-CoV-2 in inflamed IBD tissue is downregulated by HNF4A in ileum and upregulated by interferon regulating factors in colon 94%
- Antigen-driven expansion of public clonal T cell populations in inflammatory bowel diseases 94%
- An extremes of phenotype approach confirms significant genetic heterogeneity in patients with ulcerative colitis. 94%
Similar papers in this journal
- Assessing Cellular and Transcriptional diversity of IIeal Mucosa amongst Treatment Naïve and Treated Crohn’s disease 94%
- Epithelial cell biomarkers are predictive of response to biologic agents in Crohn's disease 92%
- Clonal overlap and convergent clustering of T-cell receptor signatures in Crohn's disease in monozygotic twins 92%
Similar papers in this journal
- Specific gut pathobionts escape antibody coating and are enriched during flares in patients with severe Crohn's disease 93%
- Maintenance therapy with infliximab or vedolizumab in inflammatory bowel disease is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic 91%
- CARD9 in Neutrophils Protects from Colitis and Controls Mitochondrial Metabolism and Cell Survival 91%
Similar papers in this journal
- Probing the activity of cysteine cathepsins in inflammatory bowel diseases 92%
- Linking Gene Expression to Clinical Outcomes in Pediatric Crohn's Disease Using Machine Learning 92%
- Abundance and nuclear antigen reactivity of intestinal and fecal Immunoglobulin A in lupus-prone mice at younger ages correlate with the onset of eventual systemic autoimmunity 92%
Similar papers in this journal
- Transcriptional Atlas of Ileal-Anal Pouch Immune Cells from Ulcerative Colitis Patients 93%
- Crohn's patients and healthy infants share immunodominant B cell response to commensal flagellin peptide epitopes 93%
- Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's disease 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.